Vedrana Knezevic, PA
Physician Assistant · Lexington, KYNPI 1053789750
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.3% of the total across 342 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by Medtronic at 34.7% of the total. Reporting peaked in 2022 at $3,571 and has fallen 80.9% since, to $684 in 2025. Among physician assistant clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 342 payments — averaging $30.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- AstraZeneca$919
- Novo Nordisk$868
- Boehringer Ingelheim$624
- Dexcom, Inc.$597
- Bayer$587
- plus $3K from 28 others
What the payments were for
- Travel & lodging$6777%
- Food & beverage$9,60693%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 68 | $3,571 |
| AstraZeneca(2 entities) | 34 | $919 |
| Novo Nordisk | 52 | $868 |
| Boehringer Ingelheim | 24 | $624 |
| Dexcom, Inc. | 15 | $597 |
| Bayer | 14 | $587 |
| Esperion Therapeutics, Inc. | 7 | $463 |
| Amgen(2 entities) | 11 | $446 |
| Abbott | 14 | $232 |
| AbbVie | 14 | $226 |
| Lilly USA, LLC | 11 | $177 |
| Antares Pharma, Inc. | 7 | $173 |
| Sumitomo Pharma America, Inc. | 6 | $169 |
| Mannkind Corporation | 9 | $147 |
| Xeris Pharmaceuticals, Inc. | 6 | $118 |
| Amarin Pharma, Inc. | 8 | $111 |
| Sanofi-aventis U.S. LLC | 7 | $94 |
| Corcept Therapeutics | 5 | $94 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $89 |
| Endo USA, Inc. | 3 | $83 |
| Boston Scientific | 3 | $82 |
| Zealand Pharma US, Inc. | 5 | $71 |
| 180 Medical, Inc. | 2 | $59 |
| Amryt Pharma Holdings Ltd | 3 | $55 |
| Halozyme Inc | 2 | $43 |
| BD | 2 | $42 |
| Radius Health, Inc. | 2 | $28 |
| Agiliti Surgical, Inc. | 1 | $24 |
| Pfizer | 1 | $24 |
| Coloplast | 1 | $21 |
| Urogen Pharma, Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| Ascendis Pharma Endocrinology Inc | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INPEN SMART INSULIN DELIVERY SYSTEM$489
- Kerendia$458
- InPen$367
- NEXLIZET$349
- NEXLETOL$349
- MINIMED 780G$273
- JARDIANCE$248
- Repatha$213
- MINIMED 770G$199
- Saxenda$125
- FARXIGA$112
- TEPEZZA$111
How this compares
$10,294 in reported general payments places this provider in the 95th percentile of 1,448 physician assistant providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 223 | $387,578 |
| MounjaroTirzepatide | 139 | $182,090 |
| JardianceEmpagliflozin | 102 | $134,484 |
| TrulicityDulaglutide | 75 | $124,545 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 104 | $107,781 |
| FarxigaDapagliflozin Propanediol | 78 | $105,053 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 48 | $71,310 |
| Humalog Kwikpen U-200Insulin Lispro | 23 | $56,877 |
| Tresiba Flextouch U-200Insulin Degludec | 33 | $53,926 |
| Humulin R U-500Insulin Regular, Human | 26 | $38,030 |
| Tresiba Flextouch U-100Insulin Degludec | 53 | $32,333 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 36 | $29,455 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $28,924 |
| Novolog FlexpenInsulin Aspart | 67 | $27,144 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 55 | $23,737 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog | $868 | $392,653237 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro | $177 | $319,160258 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $624 | $151,723120 claims |
| AstraZenecaFarxiga | $919 | $105,05378 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $94 | $71,31048 claims |
| AbbVieSynthroid, Armour Thyroid | $226 | $6,52074 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,448 physician assistant providers in Kentucky.
Other physician assistant in Lexington
- Brandice HarrisonLexington$745K
- Lauren MeadeLexington$656K
- Julie GurwellLexington$15K
- Amber ErwinLexington$15K
- Megan CraftLexington$13K
- Julena AdamsLexington$11K
- Kristi PhelpsLexington$10K
- Elizabeth MentzerLexington$10K
- Edwin RobbinsLexington$10K
- Sarah DoughertyLexington$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.